Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 14;28(6):1127–1135. doi: 10.1158/1078-0432.CCR-21-2595

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©2021 The Authors; Published by the American Association for Cancer Research

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

PMC Copyright notice

Figure 2. Best percentage change from baseline in target lesion size by investigator assessment in evaluable patients. Waterfall plots for best percentage change in target lesion size are shown for evaluable patients in phase II. The color key indicates the response to 300 mg twice a day of abivertinib. Abbreviation: NE, not evaluable — Best percentage change from baseline in target lesion size by investigator assessment in evaluable patients. Waterfall plots for best percentage change in target lesion size are shown for evaluable patients in phase II. The color key indicates the response to 300 mg twice a day of abivertinib. Abbreviation: NE, not evaluable